1 / 7

Carcinoembryonic Antigen Market to grow at 6% CAGR from 2016 to 2023

Get more details @ http://bit.ly/2pqae1Q <br>Companies operating in carcinoembryonic antigen market includes Abbott Diagnostics, Roche Diagnostics, Quest Diagnostics and GenWay Biotech. Companies operating in this industry are focussing on strategies such as mergers and acquisitions to maintain leadership position.

jueekate
Download Presentation

Carcinoembryonic Antigen Market to grow at 6% CAGR from 2016 to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CarcinoembryonicAntigen Market to reach $2.7bn by 2023: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. KeyInsights from Carcinoembryonic AntigenMarket: • Continuous advancement in technology in the development of new biomarkers which is used in combination with other biomarkers is anticipated to accelerate carcinoembryonic antigen market demand over the forecast period. • Global Market Insights, Inc. says (CEA) Carcinoembryonic Antigen Market size is expected to exceed USD 2.7 billion by 2023; according to a new research report by Global Market Insights, Inc. • The benefits associated with minimally invasive diagnostics practice include higher patient satisfaction as they need minor incision injuries. Furthermore, these procedures comprise less hospital stay and hence, are economically feasible and involve fewer post procedure difficulties. • The development of new immunological procedure such as radioimmunoassay is expected to increase the demand for the CEA market over the forecast timeframe.

  3. Continued... • Colorectal cancer application segment generated major revenue share of over 40% in the carcinoembryonic antigen market, and is estimated to exceed USD 1 billion by 2023. • Breast cancer is rapidly growing application segment and it is anticipated to grow at a CAGR of 7.4% by 2023. • Latin America accounted for over 5.01% of the global industry share in 2015. Changing lifestyle, excessive smoking and alcohol consumption are driving the industry growth in the region. • North America led by U.S. carcinoembryonic antigen market accounted for over 75% revenue share in 2015, due to high patient awareness levels, high incidence rates of cancer and existence of sophisticated healthcare infrastructure in the region. • Europe CEA market, was dominated by Germany with over USD 100 million revenue.

  4. Germany Carcinoembryonic Antigen (CEA) Market size, by application, 2012-2023 (USD Million)

  5. Browse Full Market Research Report On Carcinoembryonic Antigen Market @ http://bit.ly/2pqae1Q Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/427https://www.gminsights.com/request-sample/detail/49

  6. Continued... • Asia Pacific carcinoembryonic antigen market share will witness significant gain growing at 7.5% CAGR. • Breast cancer is forecast to exceed USD 466 million by 2023. Due to the rising number of female population, growing need for Hormone Replacement Therapy (HRT) and cosmetic surgeries. • Industry participants in the CEA market include Abbott Diagnostics, Roche Diagnostics, Quest Diagnostics and GenWay Biotech.

  7. Stay In Touch Website: www.gminsights.com Social Media:

More Related